Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Business Wire India Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States…